本页面由Tiger Trade Technology Pte. Ltd.提供服务

Corvus Pharmaceuticals, Inc.

10.05
-0.4700-4.47%
盘后:10.05-0.0026-0.03%19:30 EDT
成交量:71.97万
成交额:728.11万
市值:8.42亿
市盈率:-16.07
高:10.52
开:10.43
低:10.02
收:10.52
52周最高:26.95
52周最低:6.39
股本:8,376.77万
流通股本:7,412.01万
量比:0.57
换手率:0.97%
股息:- -
股息率:- -
每股收益(TTM):-0.6252
每股收益(LYR):-0.5320
净资产收益率:-35.43%
总资产收益率:-21.66%
市净率:3.74
市盈率(LYR):-18.89

数据加载中...

2021/09/30

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/23

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/02

重要事件披露

8-K - Current report
2021/08/02

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/15

重要事件披露

8-K - Current report
2021/06/16

重要事件披露

8-K - Current report
2021/05/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/29

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/29

重要事件披露

8-K - Current report
2021/03/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/25

重要事件披露

8-K - Current report
2021/03/22

重要事件披露

8-K - Current report
2021/02/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/17

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals